NeutropeniaFebrile NeutropeniaChemotherapy-Induced Febrile NeutropeniaAntineoplastic Combined Chemotherapy ProtocolsFeverTaxoidsDrug Administration ScheduleChemotherapy, AdjuvantTreatment OutcomeGranulocyte Colony-Stimulating FactorAntineoplastic AgentsCisplatinPaclitaxelDoxorubicinNeoplasmsCyclophosphamideInfusions, IntravenousDeoxycytidineVinblastineDisease-Free SurvivalCombined Modality TherapySurvival AnalysisAntineoplastic Agents, PhytogenicCamptothecinLung NeoplasmsCarboplatinMaximum Tolerated DoseBreast NeoplasmsSurvival RateAgranulocytosisEtoposideDose-Response Relationship, DrugNeoplasm StagingOrganoplatinum CompoundsIfosfamideThrombocytopeniaFever of Unknown OriginMycosesHematologic DiseasesFluorouracilLeukopeniaNeoadjuvant TherapyNeoplasm MetastasisHematologic NeoplasmsCarcinoma, Non-Small-Cell LungNauseaAntimetabolites, AntineoplasticEpirubicinAnthracyclinesSalvage TherapyNeoplasm Recurrence, LocalProspective StudiesBacterial InfectionsPrognosisLymphoma, Non-HodgkinMethotrexateAnti-Bacterial AgentsToxicity TestsDrug Resistance, NeoplasmMucositisOpportunistic InfectionsAdministration, OralVomitingTime FactorsLeucovorinAntibiotic ProphylaxisAdenocarcinomaTegafurImmunocompromised HostOxonic AcidAntineoplastic Agents, AlkylatingMitoxantroneDrug-Related Side Effects and Adverse ReactionsDisease ProgressionOvarian NeoplasmsLeukocyte CountPenicillanic AcidFollow-Up StudiesAntibiotics, AntineoplasticBleomycinFeasibility StudiesTopotecanRecombinant ProteinsPlatinum CompoundsKaplan-Meier EstimateVincristineAntibodies, Monoclonal, HumanizedGuanineAlopeciaBridged CompoundsBacteremiaStomatitisColorectal NeoplasmsStomach NeoplasmsAntifungal AgentsRecurrenceRetrospective StudiesAntibodies, Monoclonal, Murine-DerivedGlutamatesTransplantation, Autologous